Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation
- PMID: 14519683
- DOI: 10.1093/hmg/ddg327
Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation
Abstract
The neuromuscular disorder facioscapulohumeral muscular dystrophy (FSHD) results from integral deletions of the subtelomeric repeat D4Z4 on chromosome 4q. A disruption of chromatin structure affecting gene expression is thought to underlie the pathophysiology. The global gene expression profiling of mature muscle tissue presented here provides the first insight into an FSHD-specific defect in myogenic differentiation. FSHD expression profiles generated by oligonucleotide microarrays were compared with those from normal muscle as well as other types of muscular dystrophies (DMD, aSGD) in order to determine FSHD-specific changes. In addition, matched biopsies (affected and unaffected muscle) from individuals with FSHD served to monitor expression changes during the progression of the disease as well as to diminish non-specific changes resulting from individual variability. Among genes altered in an FSHD-specific and highly significant manner, many are involved in myogenic differentiation and suggest a partial block in the normal differentiation program. Indeed, many of the transcripts affected in FSHD represent direct targets of the transcription factor MyoD. Additional mis-expressed genes confirm a diminished capacity to buffer oxidative stress, as demonstrated in FSHD myoblasts. This enhanced vulnerability of proliferative stage myoblasts to reactive oxygen species is also disease-specific, further implicating a defect in FSHD muscle satellite cells. Importantly, none of the genes localizing to the FSHD region at 4q35 were found to exhibit a significantly altered pattern of expression in FSHD muscle. This finding was corroborated by expression analysis of FSHD muscle using a custom cDNA microarray containing 51 genes and ESTs from the 4q35 region. Disruptions in FSHD myogenesis and oxidative capacity may therefore not arise from a position effect mechanism as has been previously suggested, but rather from a global effect on gene regulation. Improper nuclear localization of 4qter is discussed as an alternative model for FSHD gene regulation and pathogenesis.
Similar articles
-
Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.Neurology. 2007 Feb 20;68(8):569-77. doi: 10.1212/01.wnl.0000251269.31442.d9. Epub 2006 Dec 6. Neurology. 2007. PMID: 17151338
-
FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients.J Med Genet. 2004 Nov;41(11):826-36. doi: 10.1136/jmg.2004.019364. J Med Genet. 2004. PMID: 15520407 Free PMC article.
-
Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q.Hum Mol Genet. 2003 Nov 15;12(22):2909-21. doi: 10.1093/hmg/ddg323. Epub 2003 Sep 23. Hum Mol Genet. 2003. PMID: 14506132
-
Molecular diagnosis of facioscapulohumeral muscular dystrophy.Expert Rev Mol Diagn. 2002 Mar;2(2):160-71. doi: 10.1586/14737159.2.2.160. Expert Rev Mol Diagn. 2002. PMID: 11962336 Review.
-
Facioscapulohumeral muscular dystrophy: do neurotrophins play a role?Muscle Nerve. 2010 Jan;41(1):120-7. doi: 10.1002/mus.21505. Muscle Nerve. 2010. PMID: 19813193 Review.
Cited by
-
DUX4 promotes transcription of FRG2 by directly activating its promoter in facioscapulohumeral muscular dystrophy.Skelet Muscle. 2014 Oct 24;4:19. doi: 10.1186/2044-5040-4-19. eCollection 2014. Skelet Muscle. 2014. PMID: 25789155 Free PMC article.
-
Considerations and practical implications of performing a phenotypic CRISPR/Cas survival screen.PLoS One. 2022 Feb 17;17(2):e0263262. doi: 10.1371/journal.pone.0263262. eCollection 2022. PLoS One. 2022. PMID: 35176052 Free PMC article.
-
Transgenic Drosophila for Investigating DUX4 and FRG1, Two Genes Associated with Facioscapulohumeral Muscular Dystrophy (FSHD).PLoS One. 2016 Mar 4;11(3):e0150938. doi: 10.1371/journal.pone.0150938. eCollection 2016. PLoS One. 2016. PMID: 26942723 Free PMC article.
-
A muscle stem cell for every muscle: variability of satellite cell biology among different muscle groups.Front Aging Neurosci. 2015 Oct 7;7:190. doi: 10.3389/fnagi.2015.00190. eCollection 2015. Front Aging Neurosci. 2015. PMID: 26500547 Free PMC article. Review.
-
Deciphering transcription dysregulation in FSH muscular dystrophy.J Hum Genet. 2012 Aug;57(8):477-84. doi: 10.1038/jhg.2012.74. Epub 2012 Jun 21. J Hum Genet. 2012. PMID: 22718021 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources